Dendritic cells bearing HLA-G inhibit T-cell activation in type 1 diabetes

Iranian Journal of Allergy, Asthma and Immunology

Volumn 6, Issue 1, 2007, Pages 1-7

  Abediankenari, Saeid ^a   Eslami, Mohammad Bagher ^a   Sarrafnejad, Abdolfattah ^a   Mohseni, Mehrnosh ^a   Larijani, Bagher ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autoimmunity; Dendritic cell; Diabetes type 1; HLA G; IFN (interferon )

Indexed keywords

BETA INTERFERON; HLA G ANTIGEN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIXED LYMPHOCYTE REACTION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ADOLESCENT; ADULT; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERFERON-BETA; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 33847679533     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Azam A, Eisenbarth G. Immunopathogenesis and Immunotherapeutic approaches to type 1A diabetes. Expert Opinion 2004; (4)10:1569-75.
2. Roep Bo. The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure. Diabetologia 2003; 46(3):305-21.
3. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002; 2(2):116-26.
4. Roep Bo. T-cell responses to autoantigens in IDDM. The search for the Holy Grail. Diabetes 1996; 45(9):1147-56.
5. Biron CA. Interferons alpha and beta as immune regulators - a new look. Immunity 2001; 14(6):661-4.
6. Karp C, Biron CA, Irani DN. Interferon beta in multiple sclerosis: is IL-12 suppression the key? Immunol Today 2000; 21(1):24-8.
7. Jun HS, Yoon JW. The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia 2001; 44(3):271-85.
8. So lene Le Rond, Joel Le Maoult, Caroline ereput. All reactive CD4 and Cd8 T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients. Transplantation 2001; 34:649-60.
9. Solier C, Aguerre-Girr M, Lenfax F, Campan A, Berrebi A, Rebmann V, et al. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 2002; 32(12):3576-86.
10. Bain D, Shirley A, Sargent I. HLA-G suppress proliferation of CD4 T lymphocyte. J Rep Immunol 2000; 48:17-26.
11. Buker J, Rebmann v, Grosse-wilde H, Lubold H, Ruebben H, Drexler I, et al. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma. Cancer Res 2003; 63(14):4107-11.
12. Creput C, Durrbach A, Menier C, Guettier C, samule D, Dausset J, et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 2003; 39(4):587-94.
13. Finardi E, Rizzo R, Melchiori L, Vaghi L, Castellazzi M, Govoni V, et al. Presence of detectable levels of soluble HLA-G molecules in csf of relapsing-remitting multiple sclerosis: relationship with csf soluble HLA-I and IL-10concentrations and MRI finding. J Neuroimmunol 2003; 142(1-2):149-58.
14. Gray DW, Mortis PJ. Developments in isolated pancreatic islet transplantation. Transplantation 1987; 43(3):321-31.
15. Thumann P, Moc I, Humrich J, Berger TG, Schultz ES, Schuler G, et al. Antigen loading of dendritic cells with whole tumor cell preparations. J Immunol Methods 2003; 277(1-2):1-16.
16. Wagner L, Templ E, Reining G, Base W, Weissel M, Nowotny P, et al. Culture of human insulinoma cells :development of a neuroendocrine tumor cell and human pancreatic islet cell-specific monoclonal antibody. J Endocrinol 1998; 156(3):469-76.
17. Boyer RF. Modern Experimental Biochemistry. The Benjamin Cummings Publishing Company: Redwood City California, 2000: 269-97.
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65(1-2):55-63
19. Severa M, Remoli ME, Giacomini E, Ragimbeau J, Lande R, Uze G, et al. Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expression. J Leukoc Biol 2006; 79(6):1286-94.
20. Basturk B, Karakayali F, Emiroglu R, Sozer O, Haberal A, Bal D, et al. Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation. Transplant Proc 2006; 38(2):571-4.
21. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 1997; 27(2):431-41.
22. Reder AT, Genc K, Byskosh PV, Porrini AM. Monocyte activation in multiple sclerosis. Mult Scler 1998; 4(3):162-8.
23. Wiendl H, Mitsdoerffer M, Hofmeister V, Wischhusen J, Bornemann A, Meyermann R, et al. A Functional Role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 2002; 168(9):4772-80.
24. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED. Soluble HLA-G protein secreted by allospecific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A. 2001; 98(21):12150-5.
25. Chang CC, Ciubotariu R, Manavalan JS, Yuan J, Colovai AI, Piazza F, et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002; 3(3):237-43.
26. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA, et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998; 160(7):3096-100.
27. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 2005; 19(7):681-93.
28. Lila N, Amrein C, Guillemain R, Chevalier P, Latremouille C, Fabiani JN, et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002; 105(16):1949-54.